ADENOCARCINOMA OF ENDOMETRIUM

Clinical trials for ADENOCARCINOMA OF ENDOMETRIUM explained in plain language.

Never miss a new study

Get alerted when new ADENOCARCINOMA OF ENDOMETRIUM trials appear

Sign up with your email to follow new studies for ADENOCARCINOMA OF ENDOMETRIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug duo targets Hormone-Sensitive uterine cancer

Disease control Completed

This study tested whether combining two existing drugs, fulvestrant and abemaciclib, could help control advanced endometrial cancer that had returned or persisted after other treatments. The trial involved 28 postmenopausal women whose cancer was fueled by hormones. Researchers m…

Matched conditions: ADENOCARCINOMA OF ENDOMETRIUM

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 02, 2026 02:41 UTC

ADENOCARCINOMA OF ENDOMETRIUM

Get alerted when new ADENOCARCINOMA OF ENDOMETRIUM trials appear

New drug duo targets Hormone-Sensitive uterine cancer